Dr Andrew J. Woo completed his Bachelor of Science with Honours and a Doctor of Philosophy in Biochemistry at The University of Western Australia in 2004. He then began his postdoctoral training under Dr. Alan B. Cantor’s mentorship at Children’s Hospital Boston / Dana-Faber Cancer Institute at Harvard Medical School, Boston, USA. Transcriptional gene regulation is the focus of his research and his discoveries contributed to the study of blood disorders, cancer and stem cell biology. He has published in many prestigious journals including, Cell, Journal of Clinical Investigation, Molecular Cell, Genes and Development, Nature Communications, Blood and Molecular & Cellular Biology. He has returned to Perth in 2012 with a fellowship from Royal Perth Hospital Medical Research Foundation.

Research approaches include.
- Protein-Protein Interaction identification via proteomics
- Protein-DNA interaction mapping via next generation sequencing techniques
- Transcriptomics by next generation sequencing techniques
- Functional genomics
- Transgenic Mouse Models

2015 CIA, Cancer Council of Western Australia, Perth, Australia
2015 Sole CI, Medical Research Foundation WA, Perth, Australia
2014 Sole CI, Medical Research Foundation WA, Perth, Australia
2013 Sole CI, Medical Research Foundation WA, Perth, Australia
2012 Fellowship, Medical Research Foundation WA, Perth, Australia

Postdoctoral Research Fellow
Department of Hematology and Oncology
Boston Children's Hospital / Dana-Farber Cancer Institute,
Harvard Medical School,
Boston, MA, USA.

Dr Andrew Woo’s research interests encompass understanding the transcriptional gene regulatory mechanisms in stem/progenitors cells of blood and epithelial cancer stem cells. With Dr. Peter Leedman at Harry Perkins Institute of Medical Research, he also investigates the role of small non-coding RNA processing complexes in epithelial cancer onset and metastasis.

English and Korean